Congratulations to three researchers from the Lloyd-Jones group for their recent successes at scientific meetings.
Congratulations to Prof. Paul Barlow and Dr Andy Herbert who are scientific co-founders of Gemini Therapeutics, a new medical therapeutics company that is developing treatments for a common cause of blindness - age-related macular degeneration. The company has just announced $42.5 million of venture capital investment.
Dr Stephen Moggach has been featured in an article about the Diamond Light Source in Chemistry World.
The article highlights the diverse science taking place at the facility and includes a description of Stephen's research and how the Diamond facility helps him.
A paper co-authored by Prof. Guy Lloyd-Jones has shown how gold nanoparticles could be used to release drugs inside tumours.
The research has been widely reported on, with articles appearing on the BBC and various national and international newspapers as well as coverage on Radio and TV.
Prof. Guy Lloyd-Jones has been awarded a 2018 Invitational Fellowship from the Japan Society for the Promotion of Science.
The Fellowship is "designed to enable Japanese researchers to invite their overseas colleagues to Japan to participate in cooperative work and other academic activities."
Congratulations to Dr Andy Lawrence on his award of a European Research Council (ERC) Starting Grant.
The grants are awarded to early career researchers who have already produced excellent supervised work, are ready to work independently and show potential to be a research leader.
Fantastic news and richly deserved!